|
KONECT RESILIA Aortic Valved Conduit (AVC) Real-world Study Assessing Safety and Performance
RECRUITINGSponsored by Edwards Lifesciences
Actively Recruiting
SponsorEdwards Lifesciences
Started2026-06-25
Est. completion2028-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07619872
Summary
KONECTION is a prospective, observational, single-arm, multicenter study designed to collect real-world clinical outcomes in up to 250 participants who will receive the KONECT RESILIA aortic valved conduit, Model 11060A.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: 1. 18 years or older at the time of informed consent 2. Have a diseased native or prosthetic aortic valve and a damaged or diseased ascending aorta that requires aortic valved conduit replacement surgery with the KONECT RESILIA AVC 3. Provide written informed consent 4. Willing to follow protocol requirements Exclusion Criteria: 1. Active endocarditis or endocarditis within 3 months prior to the study index procedure 2. Emergency procedure 3. Stage 4 renal disease (estimated glomerular filtration rate \[eGFR\] \<30 excluded) or requiring dialysis 4. Less than 2-year life expectancy due to non-cardiovascular life-threatening disease in the opinion of the study investigator 5. High predicted risk of mortality prior to the procedure: Society of Thoracic Surgeons Predicted Risk of Mortality (STS-PROM) ≥8%
Conditions2
Aortic Valve DiseaseHeart Disease
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorEdwards Lifesciences
Started2026-06-25
Est. completion2028-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07619872